This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Inventor Amit Kulkarni
Introduction
Amit Kulkarni is an innovative inventor based in Heidelberg, Germany. He is currently associated with the Deutsches Krebsforschungszentrum - Stiftung Des Öffentlichen Rechts / Universität Heidelberg. His work primarily focuses on cancer research, particularly in the area of oncolytic virus therapy.
Latest Patent Applications
Amit Kulkarni has filed a patent application titled "Method for Predicting the Clinical Response of Oncolytic Parvovirus H1 (H-1PV) Treatment in a Patient Suspected of Suffering from Cancer by Measuring the Expression Levels of Laminins and/or Galectins as Biomarkers in a Patient's Sample." This invention concerns the use of laminins and/or galectins as biomarkers for predicting the outcome of treatment with oncolytic parvovirus H1 in cancer patients.
Conclusion
Amit Kulkarni's contributions to cancer research through his innovative patent application highlight his commitment to advancing medical science. His work has the potential to significantly impact the treatment of cancer patients in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile